Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Scientists have discovered that a rare “mirror-image” version of the amino acid cysteine can dramatically slow the growth of ...

Pioneering clinical trial testing how personalised mRNA vaccines can enable the immune system to target recurring pancreatic cancer.

New research published in Nature finds that tumor cells within supratentorial ependymomas (SE) – an aggressive childhood brain cancer – cluster into distinct tumor cell populations. Much like a ...

Scientists have long been fascinated by tiny molecules called polyamines. These molecules exist in every living cell, from simple bacteria to human beings. They help cells grow, divide, and carry out ...

A new study led by researchers at Adelaide University and published in Science Advances reveals why some cancers can grow and survive in the body, while others cannot. It turns out that intense ...

An abnormal Pap smear result doesn’t necessarily mean you have cervical cancer. Your doctor may recommend further testing as a next step.

A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...

I think we’ll carry on with what we’re doing,’ said my consultant, for what felt like the hundredth time, in January. And yet ...

A chronological map of the fetal brain reveals when key cells emerge and provides clues about autism and cancer.

Breast cancer grading helps doctors understand how aggressive a tumour may be. Dr Bhavisha Ghugare of HCG Cancer Centre, Borivali explains the difference between Grade 1, Grade 2 and Grade 3 breast ...